XNCR today
$37.09-$1.04 (-2.73%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourBearish
1 hourStrong Bearish
15 minStrong Bearish
5 minBullish
Daily trend turns down below $27.76
Key levels
Resistance$40.60
Resistance$38.08
Support$35.92
Support$33.60
Latest news & SEC filings
NewsXencor Executive Offloads Stock Valued Above $3 Million
SEC FilingXencor Inc filed an insider trading report (Form 4)
AnalystCCORF Repeats Positive Stance on Xencor, Keeps $40 Target
All XNCR news →About Xencor
Xencor is a clinical-stage biopharmaceutical company that discovers and develops engineered antibody therapeutics for cancer and autoimmune diseases. It designs Fc domains and multi-specific antibody formats, including T-cell engaging bispecific antibodies, under its XmAb technology platform. The company advances its own drug candidates through clinical trials and licenses technologies and candidates to partners such as Amgen, Incyte, Zenas and Novartis. Its operations are based in the United States.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
Xencor Inc (XNCR)
What Is the Price Target for XNCR?
SEPT Low Target
$36.55
SEPT Mid Target
$43.00
SEPT High Target
$49.45
Analyst Consensus
$43.00
Is XNCR a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for XNCR.
Start Free Trial →Is XNCR Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$57.73
25
Moat Score
NONE
3/9
Piotroski Score
4.3
Altman Z-Score
What Is Smart Money Doing with XNCR?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cornelissen Bart Jan | officer | Sale | 10,100 | $402K | Nov 11, 2026 |
| RANIERI RICHARD J | director | Buy | 15,000 | $346K | Nov 10, 2026 |
| RANIERI RICHARD J | director | Buy | 21,412 | $569K | Nov 10, 2026 |
| RANIERI RICHARD J | director | Buy | 11,971 | $255K | Nov 10, 2026 |
| RANIERI RICHARD J | director | Buy | 27,372 | $258K | Nov 10, 2026 |
| RANIERI RICHARD J | director | Sale | 70,080 | $2.7M | Nov 10, 2026 |
| RANIERI RICHARD J | director | Sale | 11,172 | $442K | Nov 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →XNCR Growth Story
Revenue YoY
13.7%
3yr Revenue CAGR
-8.6%
EPS Growth YoY
65.36%
FCF Growth YoY
33.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for XNCR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for XNCR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:17 | $37.09 | 1,107 | $$41K | SELL |
| 21:00:17 | $37.09 | 4,300 | $$159K | SELL |
| 21:00:10 | $37.09 | 3,500 | $$130K | SELL |
| 21:00:01 | $37.09 | 1,000 | $$37K | BUY |
| 20:57:23 | $37.33 | 1,200 | $$45K | BUY |
5 dark pool trades shown · $$412K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Xencor Inc (XNCR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →XNCR — frequently asked questions
What is XNCR stock price today?
Xencor Inc (XNCR) is at $37.09, down 2.73% (-$1.04) at the Nov 13, 2026 close.
Why is XNCR stock moving today?
Latest XNCR news — Nov 13, 2026: Xencor Executive Offloads Stock Valued Above $3 Million · Nov 12, 2026: Xencor Inc filed an insider trading report (Form 4)
What is the XNCR price target?
The average analyst price target for XNCR is $43.00, ranging from $21 to $46, based on 11 analysts. Latest: Truist Securities maintains on Oct 27, 2026.
What do analysts rate XNCR?
Analyst ratings for XNCR: 0 Buy, 11 Hold, 0 Sell — consensus Hold.
Did XNCR beat earnings?
XNCR last reported on Aug 5, 2026: EPS -$0.29 vs -$0.80 expected — a beat of 63.8%.
Does XNCR pay a dividend?
XNCR does not currently pay a dividend.
What are XNCR support and resistance levels?
Support: $35.92, $33.60, $30.61. Resistance: $38.08, $40.60, $43.61.
What are insiders doing with XNCR?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on XNCR?
Nov 13, 2026: Xencor Executive Offloads Stock Valued Above $3 Million · Nov 12, 2026: Xencor Inc filed an insider trading report (Form 4) · Nov 10, 2026: CCORF Repeats Positive Stance on Xencor, Keeps $40 Target